MilliporeSigma Enhances Sustainability with Expanded Green Chemistry Evaluation Tool

To help scientists, researchers and manufacturers reduce their environmental footprint, MilliporeSigma expanded its DOZN™ system — an industry-first quantitative green chemistry tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry. Through MilliporeSigma’s DOZN™ 2.0, customers can now calculate the green scores of their own processes and products. This free, web-based tool provides users with even more data so that they are properly equipped to increase their sustainability. 

Many chemists and scientists look for sustainable options in the lab, such as recycling gloves and using greener packaging. However, they may not think about the impact of green chemistry and often face the challenge of evaluating the sustainability of a chemical or process. MilliporeSigma’s DOZN™ 2.0 provides a consistent and reliable framework for measuring the greenness of chemicals and processes and communicating what’s “greener” about products labelled as “greener alternatives.” Products receive an aggregate score based on a scale of 0-100, with 0 being the most desired.

DOZN™ 2.0 instructs customers how to calculate scores for products that MilliporeSigma does not offer. Data privacy is top of mind — allowing users to score their processes and products in a secure manner. This tool is also straightforward with readily available data, such as manufacturing inputs, Safety Data Sheet and Globally Harmonized System information. As a result, customers can carry out meaningful research while positively contributing to their own environmental impact goals. 

Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

About the Corporate Responsibility Efforts of the Life Science Business of Merck KGaA, Darmstadt, Germany

Through its corporate responsibility initiatives, the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, harnesses the collective expertise, passion and energy of employees to minimize its environmental footprint and positively impact communities around the world.

The Life Science business of Merck KGaA, Darmstadt, Germany is uniquely positioned to solve the toughest problems in life science through its efforts aligned with strengths in research, innovation and collaboration with the global scientific community. This helps differentiate its business and provides a competitive edge for its customers, while accelerating access to health for people everywhere. The Life Science business of Merck KGaA, Darmstadt Germany demonstrates its commitment to corporate responsibility through extensive programs in three main areas: Greener Products and Solutions—which includes Design for Sustainability, Green Chemistry, Packaging and Recycling initiatives; Employee and Community Engagement; and Sustainable Operations.

About the Life Science Business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has approximately 21,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany generated sales of €14.8 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Back to news